LineaRx, Inc. (an Applied DNA Sciences, Inc. (NASDAQ: APDN) company) delivers enzymatically produced LinearDNA™ as an alternative to current plasmid-based DNA manufacturing processes with advantages of speed, purity, and scalability to support the next generation of nucleic acid-based therapies. Manufactured by a proprietary, large-scale polymerase chain reaction (‘PCR’)-based manufacturing platform, LinearDNA allows for the rapid and efficient cell-free production of high-fidelity DNA sequences. LinearDNA is relevant to a broad array of advanced therapeutics, including mRNA production, DNA vaccines, cell and gene therapies, as well as numerous veterinary medicine applications. Formed in 2018 to commercialize our parent company’s 20+ years of experience and leadership in enzymatic DNA production, LinearRx stands ready to deliver a new generation of DNA for the next generation of medicines.
LineaRx, We are DNA Made Simple.
Company Details
- Employees
- 2
- Address
- Stony Brook, Ny 11790, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.linearxdna.com/
- Keywords
- Biotherapeutics, Linear DNA, DNA Vaccines.
- HQ
- Stony Brook, NY
Linearx, Inc. Questions
Linearx, Inc.'s website is https://www.linearxdna.com/
Linearx, Inc.'s LinkedIn profile is https://www.linkedin.com/company/linearx-inc
Linearx, Inc. has
2 employees.
View email and phone details for 2
employees at Linearx, Inc..
Linearx, Inc.'s industry is
Biotechnology Research
Linearx, Inc.'s top competitors are
Applied Dna Sciences,
Quantoom Biosciences,
Eclipsebio,
Syngoi Technologies,
Bia Separations Inc.,
Hongene Biotech Corporation,
Spindle Biotech Inc.,
Revolution Biomanufacturing Inc.,
Ba Sciences,
Aldevron.
Linearx, Inc.'s categories are Biotechnology Research
